Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ABIOMED, Inc. - Common Stock
(NQ:
ABMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ABIOMED, Inc. - Common Stock
< Previous
1
2
3
Next >
Risk Vs Reward Vs Folly: Navigating Investment Choices
↗
September 29, 2023
During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of...
Via
Talk Markets
Is It Too Late to Buy Johnson & Johnson's Stock?
↗
April 28, 2023
This healthcare juggernaut's recent quarterly results prove just how strong its business is.
Via
The Motley Fool
2 Best Buffett Stocks to Buy for the Long Haul
↗
December 27, 2022
Both of these stocks look like bargains right now.
Via
The Motley Fool
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
↗
December 21, 2022
Even if interest rates go up, you likely won't need to worry about these stocks.
Via
The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
↗
December 21, 2022
The investments you make now could power your portfolio returns for years to come.
Via
The Motley Fool
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
↗
December 16, 2022
There's a lot more ahead for these market giants.
Via
The Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today
↗
December 08, 2022
Via
Benzinga
Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years
↗
November 21, 2022
Via
Benzinga
Will Investors Notice Exciting Sign On Abiomed's Chart?
↗
November 16, 2022
Via
Benzinga
Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?
↗
December 14, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI...
Via
Benzinga
2 Top Dividend Kings to Buy for the Long Haul
↗
December 14, 2022
No matter how much changes, these two healthcare giants keep performing.
Via
The Motley Fool
This Monster Dividend Stock Isn't Done Growing
↗
December 08, 2022
Is another deal on the way for Johnson & Johnson?
Via
The Motley Fool
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
↗
December 05, 2022
There are now two companies in the ring for a Horizon takeover.
Via
Investor's Business Daily
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
↗
December 02, 2022
This space is ripe with opportunities for investors.
Via
The Motley Fool
Beat the Dow Jones With This Unstoppable Dividend Stock
↗
November 05, 2022
Johnson & Johnson has outperformed the Dow so far this year.
Via
The Motley Fool
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
↗
November 30, 2022
Via
Benzinga
Bear Market Blues? 3 of the Best Stocks to Own in 2023
↗
November 19, 2022
2023 could be a big year for each of these healthcare companies.
Via
The Motley Fool
Peering Into Abiomed's Recent Short Interest
↗
November 17, 2022
Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 5.96% of all regular shares that...
Via
Benzinga
2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield
↗
November 11, 2022
Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year?
Via
The Motley Fool
Better Buy: Johnson & Johnson vs. Abbott Laboratories
↗
November 10, 2022
These two healthcare giants are among the safest stocks investors can buy right now.
Via
The Motley Fool
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
↗
November 10, 2022
The company is planting seeds for future growth.
Via
The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
↗
November 08, 2022
These robust businesses will be around well beyond the next 10 years.
Via
The Motley Fool
3 No-Brainer Stocks to Buy in a Downturn
↗
November 08, 2022
These companies thrive when others falter.
Via
The Motley Fool
Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
↗
November 05, 2022
Plus, we run through some shortcuts that could help you with your financial planning.
Via
The Motley Fool
Is Johnson & Johnson's Purchase of Abiomed Good for Investors?
↗
November 05, 2022
The $16.6 billion acquisition shakes up MedTech.
Via
The Motley Fool
Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review
↗
November 04, 2022
A mixed jobs report and heavy earnings swung stocks.
Via
Investor's Business Daily
Here's How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today
↗
November 04, 2022
Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average annual return of 25.63%. Currently, Abiomed has a market capitalization of...
Via
Benzinga
5 Analysts Have This to Say About Abiomed
↗
November 02, 2022
Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
↗
November 02, 2022
Upgrades
Via
Benzinga
Is Johnson & Johnson an Underrated Growth Stock?
↗
November 02, 2022
Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium.
Via
The Motley Fool
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
